SEC Form 4 · accession 0001127602-18-026464
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Kuntz
Officer — SVP & Chief Medical & Science
Period of report
Aug 28, 2018
Accepted (ET)
Aug 29, 2018 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Aug 28, 2018 | M | 41,227 | $38.81 | A | 152,579 | D | |
| Ordinary SharesF1 | Aug 28, 2018 | S | 47,176 | $95.8769 | D | 105,403 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $38.81 | Aug 28, 2018 | M | 41,227 | D | — | Jul 30, 2022 | Ordinary Shares | 41,227 | 0 | D |
Explanation of responses
- F1The price is a weighted average price. These shares were sold in multiple transactions in prices ranging from $95.82 to $95.9850, inclusive. The reporting person undertakes to provide to Medtronic plc, any security holder of Medtronic plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote in this Form 4.
- F2This option to purchase 41,227 New Medtronic ordinary shares for $38.81 per share, which was partially vested at the effective time of the Merger, was received in the Merger and represents the conversion of 41,227 Medtronic common stock shares for $38.81 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.